https://doi.org/10.4081/reumatismo.2020.1267
Different fracture risk profile in patients treated with anti-osteoporotic drugs in real-life
Accepted: 15 April 2020
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
In this retrospective study, we intended to investigate the baseline fracture risk profile in patients who started treatment with different anti-osteoporotic medications. We analyzed retrospectively the fracture risk calculated with DeFRA, a validated FRAX derived tool, in women who started an anti-osteoporotic treatment from 2010 to 2017. We analyzed baseline data of 12,024 post-menopausal women aged over 50 years. Teriparatide initiators had a baseline 10-year risk of major osteoporotic fracture of 82.1% with a Standard Deviation (SD) of 66.5%. Denosumab initiators and zoledronic acid initiators had a greater 10-year baseline risk of fracture (54.3%, SD 46.5% and 47.0%, SD 42.0 respectively) than patients initiated on alendronate (24.9%, SD 34.6%) and patients initiated on risedronate (23.9%, SD 24.1%). Using DeFRA, a FRAX™ derived tool, we showed significantly different fracture risk profiles in women who were started on various therapeutic agents for the treatment of osteoporosis in routine clinical practice.
How to Cite
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
Similar Articles
- N. Ughi, D.P. Bernasconi, C. Gagliardi, F. Del Gaudio, A. Dicuonzo, A. Maloberti, C. Giannattasio, C. Rossetti, M.G. Valsecchi, O.M. Epis, Trends in severe outcomes in SARS-CoV-2-positive hospitalized patients with rheumatic diseases: a monocentric observational and case-control study in northern Italy , Reumatismo: Vol. 75 No. 2 (2023)
- F.H.C. De Souza, D.B. De Araújo, L.S. Hoff, B.G. Baldi, M.S.M.S. Faria, L.F da Rocha Junior, L.R.S Da Silva, G.L Behrens Pinto, M.C. Bezerra, R. Miossi, R.A. Cordeiro, S.K Shinjo, Diagnosis and treatment of interstitial lung disease related to systemic autoimmune myopathies: a narrative review , Reumatismo: Vol. 75 No. 1 (2023)
- S. Sülükcü, S. Uslu, Assessment of liver and kidney function in patients with ankylosing spondylitis on long-term non-steroidal anti-inflammatory drug therapy , Reumatismo: Vol. 76 No. 4 (2024)
- E. Filippucci, A. Farina, F. Bartolucci, C. Spallacci, P. Busilacchi, W. Grassi, Fluoroquinolone-induced bilateral rupture of the Achilles tendon: clinical and sonographic findings , Reumatismo: Vol. 55 No. 4 (2003)
- Ennio Lubrano, Alessandro Armuzzi, Silvia Scriffignano, Carla Felice, Fabio Massimo Perrotta, Vincenzo Venerito, Sergio Del Vescovo, Roberta Ramonda, Giulia Cassone, Fabiola Atzeni, Roberto Caporali, Fabrizio Conti, Elisa Gremese, Florenzo Iannone, Marco Sebastiani, Ennio Giulio Favalli, The holistic management of peripheral spondyloarthritis: focus on articular involvement in patients with inflammatory bowel disease , Reumatismo: Vol. 77 No. 1 (2025)
- C. Botsios, P. Ostuni, P. Sfriso, A. Furlan, U. Fiocco, D. Sgarabotto, S. Todesco, Infections in patients with rheumatoid arthritis receiving anti-cytokine therapy: biological mechanisms and clinical aspects , Reumatismo: Vol. 55 No. 4 (2003)
- C. Tani, L. Carli, M. Mosca, C. Baldini, A. Consensi, M. Doveri, R. Talarico, S. Bombardieri, Adherence to cervical cancer screening in an Italian SLE cohort , Reumatismo: Vol. 63 No. 1 (2011)
- R. Ramírez-Sandoval, M. Vázquez-del-Mercado, Caspase 3 blocking avoids the expression of autoantigens triggered by apoptosis in neonatal Balb/c mice skin , Reumatismo: Vol. 63 No. 1 (2011)
- R. Boni, P.G. Rabitti, Spinning-induced rhabdomyolysis: importance of MRI for patient’s outcome. A case report , Reumatismo: Vol. 63 No. 1 (2011)
- C. Nalli, L. Andreoli, M. Motta, G.L. Norman, Z. Shums, W.L. Binder, M. Nuzzo, M. Frassi, A. Lojacono, A. Meini, V. Medeghini, T. Avcin, P.L. Meroni, A. Tincani, Fine specificity of anti-beta2glycoprotein I antibodies in systemic autoimmune diseases is mostly directed against domain 1 , Reumatismo: Vol. 63 No. 2 (2011)
<< < 5 6 7 8 9 10 11 12 13 14 > >>
You may also start an advanced similarity search for this article.
